Covariate adjustment uses baseline prognostic variables to improve the precision of treatment effect estimates. Recent Food and Drug Administration guidance and scientific consensus emphasize three principles for its use, namely estimand-focused analyses, assumption-lean robustness, and fit-for-purpose variance estimation. Despite substantial methodological progress, practical guidance for trial practitioners remains fragmented. We review covariate adjustment strategies for continuous, discrete, and time-to-event endpoints in randomized trials that adhere to these three principles. We show how unadjusted estimators, as well as linear and non-linear adjusted estimators, can be viewed as special cases of the general augmented inverse probability weighting framework. For time-to-event endpoints, we describe how covariate adjustment can be applied to Kaplan-Meier estimators, log-rank tests, and estimation of the unconditional hazard ratio without altering the estimand or introducing additional assumptions. We also synthesize recent developments in multi-arm trials, covariate-adaptive randomization, data-adaptive covariate selection, and covariate adjustment in interim analyses, and we provide practical insights for implementation. Covariate-adjusted estimators target the same marginal estimands as unadjusted analyses but typically achieve greater efficiency. Linear adjustment with Analysis of Heterogeneous Covariance guarantees asymptotic efficiency gains under minimal assumptions. Augmented inverse probability weighting generalizes covariate adjustment to flexible modeling frameworks and remains consistent even under model misspecification. For survival analysis, covariate-adjusted versions of the log-rank test and Cox model improve power without altering the estimand or requiring additional assumptions. Properly accounting for covariate-adaptive randomization is essential for valid inference. The reviewed methods are implemented in the RobinCar family of R packages: RobinCar and RobinCar2. Covariate adjustment is a principled and practical approach for improving trial efficiency, aligned with current regulatory guidance. By adhering to the principles of estimand-focus, assumption-lean robustness, and fit-for-purpose variance estimation, practitioners can apply covariate adjustment with confidence across diverse trial settings. Further work on evaluating finite-sample performance and re-analyses of completed trials will deepen understanding of covariate adjustment in practice.
Bannick et al. (Sat,) studied this question.